The Immunogenicity of a Foot-and-Mouth Disease Virus Serotype O Vaccine in Commercial and Subsistence Cattle Herds in Zambia

被引：2

作者：

Banda, Frank ^{[1
,2
]}

Ludi, Anna B. ^{[3
]}

Wilsden, Ginette ^{[3
]}

Browning, Clare ^{[3
]}

Kangwa, Henry L. ^{[1
]}

Mooya, Lynnfield ^{[1
]}

Ngoma, Masuzyo ^{[1
]}

Muuka, Geoffrey M. ^{[4
]}

Mundia, Cornelius ^{[4
]}

Fandamu, Paul ^{[4
]}

Paton, David J. ^{[3
]}

King, Donald P. ^{[3
]}

Quan, Melvyn ^{[2
]}

机构：

[1] Cent Vet Res Inst, Virol Unit, Lusaka 10101, Zambia

[2] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, ZA-0110 Pretoria, South Africa

[3] Pirbright Inst, Pirbright GU24 0NF, England

[4] Minist Fisheries & Livestock, Dept Vet Serv, Lusaka 10101, Zambia

来源：

VACCINES | 2023年 / 11卷 / 12期

关键词：

foot-and-mouth disease; immunogenicity; vaccine; field evaluation; POTENCY VACCINES; ELISA; VALIDATION;

D O I：

10.3390/vaccines11121818

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The recent introduction of foot-and-mouth disease (FMD) virus serotype O (O/EA-2 topotype) in Southern Africa has changed the epidemiology of the disease and vaccine requirements of the region. Commercial and subsistence cattle herds in Zambia were vaccinated with an FMD virus serotype O Manisa vaccine according to a double- or single-dose vaccination schedule. Heterologous antibody responses induced by this vaccine against a representative O/EA-2 virus from Zambia were determined. Virus neutralisation tests (VNTs) showed double-dosed cattle had a mean reciprocal log virus neutralisation titre of 2.02 (standard error [SE] = 0.16, n = 9) for commercial herds and 1.65 (SE = 0.17, n = 5) for subsistence herds 56 days after the first vaccination (dpv). Significantly lower mean titres were observed for single-dosed commercial herds (0.90, SE = 0.08, n = 9) and subsistence herds (1.15, SE = 0.18, n = 3) 56 dpv. A comparison of these results and those generated by solid-phase competitive ELISA (SPCE) tests showed a statistically significant positive correlation by Cohen's kappa coefficient. Therefore, SPCE might be used in assessing the immunogenicity of vaccines in place of VNT. Furthermore, for this vaccine and field strain, a vaccination regime employing a two-dose primary course and revaccination after 4-6 months is likely to be appropriate.

引用

页数：8

共 50 条

[31] Dromedaries (Camelus dromedarius) are of Low Susceptibility to Inoculation with Foot-and-Mouth Disease Virus Serotype O [J].

Alexandersen, S. ;

Wernery, U. ;

Nagy, P. ;

Frederiksen, Tina ;

Normann, Preben .

JOURNAL OF COMPARATIVE PATHOLOGY, 2008, 139 (04) :187-193

[32] Selection of Vaccine Candidate for Foot-and-Mouth Disease Virus Serotype O Using a Blocking Enzyme-Linked Immunosorbent Assay [J].

Cao, Yimei ;

Li, Kun ;

Xing, Xiangchuan ;

Bao, Huifang ;

Huang, Nana ;

Zhu, Guoqiang ;

Bai, Xingwen ;

Sun, Pu ;

Fu, Yuanfang ;

Li, Pinghua ;

Zhang, Jing ;

Ma, Xueqing ;

Li, Dong ;

Liu, Zaixin ;

Lu, Zengjun .

VACCINES, 2021, 9 (04)

[33] BoLA-DR peptide binding pockets are fundamental for foot-and-mouth disease virus vaccine design in cattle [J].

Baxter, R. ;

Craigmile, S. C. ;

Haley, C. ;

Douglas, A. J. ;

Williams, J. L. ;

Glass, E. J. .

VACCINE, 2009, 28 (01) :28-37

[34] Genetic identification and serological evaluation of commercial inactivated foot-and-mouth disease virus vaccine in pigs [J].

Je, Sang H. ;

Kwon, Taeyong ;

Yoo, Sung J. ;

Lee, Dong-Uk ;

Seo, Sang Won ;

Byun, Jeong J. ;

Shin, Jeong Y. ;

Lyoo, Young S. .

CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2018, 7 (02) :139-144

[35] Foot-and-mouth disease virus [J].

Domingo, E ;

Baranowski, E ;

Escarmís, C ;

Sobrino, F .

COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2002, 25 (5-6) :297-308

[36] Foot-and-mouth disease vaccine potency testing: The influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose-response curve in cattle [J].

Jamala, Syed M. ;

Bouma, Annemarie ;

van den Broek, Jan ;

Stegeman, Arjan ;

Chenard, Gilles ;

Dekker, Aldo .

VACCINE, 2008, 26 (50) :6317-6321

[37] Thermostable foot-and-mouth disease virus as a vaccine candidate for endemic countries: A perspective [J].

Hegde, Nagendra R. ;

Maddur, Mohan S. ;

Rao, Pavuluri Panduranga ;

Kaveri, Srini V. ;

Bayry, Jagadeesh .

VACCINE, 2009, 27 (16) :2199-2201

[38] Antigenic properties and virulence of foot-and-mouth disease virus rescued from full-length cDNA clone of serotype O, typical vaccine strain [J].

Kim, Rae-Hyung ;

Chu, Jia-Qi ;

Park, Jeong-Nam ;

Lee, Seo-Yong ;

Lee, Yeo-Joo ;

Ko, Mi-Kyeong ;

Hwang, Ji-Hyeon ;

Lee, Kwang-Nyeong ;

Kim, Su-Mi ;

Tark, Dongseob ;

Ko, Young-Joon ;

Lee, Hyang-Sim ;

Seo, Min-Goo ;

Park, Min-Eun ;

Kim, Byounghan ;

Park, Jong-Hyeon .

CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2015, 4 (01) :114-118

[39] Reduction of foot-and-mouth disease virus transmission in cattle vaccinated one or two weeks before challenge using a commercial polyvalent vaccine [J].

Duffy, Sergio ;

Fondevila, Norberto ;

Galdo Novo, Sabrina ;

Aznar, Maria ;

Garro, Carlos ;

Smitsaart, Eliana ;

Monti, Gustavo .

VACCINE: X, 2020, 5

[40] Expression of VP1 protein of serotype A and O of foot-and-mouth disease virus in transgenic sunnhemp plants and its immunogenicity for guinea pigs [J].

Rao, J. P. ;

Agrawal, P. ;

Mohammad, R. ;

Rao, S. K. ;

Reddy, G. R. ;

Dechamma, H. J. ;

Suryanarayana, V. V. S. .

ACTA VIROLOGICA, 2012, 56 (02) :91-99

← 1 2 3 4 5 →